ALR Technologies SG Ltd. is a data management company, which engages in providing healthcare management solutions. The company employs 6 full-time employees The company went IPO on 2000-03-13. The company has developed a comprehensive approach to diabetes care that includes: an FDA-cleared and HIPAA-compliant Diabetes Solution product that collects data from blood glucose meters (BGM) and continuous glucose monitoring device (CGM); a patent-pending Predictive A1C algorithm to track treatment success between lab reports; and an FDA-cleared Insulin Dosing Adjustment program. From this technology portfolio, the Company has developed the Diabetes Solution product for human health, and the GluCurve product for animal health. The firm is focused on the enhancement of adherence to disease and healthcare management programs through artificial intelligence, machine learning, patient monitoring, and improved communications. Its primary business markets are healthcare providers, the providers of health insurance, and the providers of disease and care management services, including the home care industry.
Follow-Up Questions
Qui est le CEO de ALR Technologies SG Ltd ?
Mr. Soongling Chan est le Chairman of the Board of Directors de ALR Technologies SG Ltd, il a rejoint l'entreprise depuis 2011.
Quelle est la performance du prix de l'action ALRTF ?
Le prix actuel de ALRTF est de $0.0182, il a decreased de 0% lors de la dernière journée de trading.
Quels sont les thèmes d'affaires principaux ou les industries de ALR Technologies SG Ltd ?
ALR Technologies SG Ltd appartient à l'industrie Health Care et le secteur est Health Care
Quel est la capitalisation boursière de ALR Technologies SG Ltd ?
La capitalisation boursière actuelle de ALR Technologies SG Ltd est de $11.6M
